Background: The utilization of non-lung organs from deceased donors with a positive polymerase chain reaction (PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the time of donation can be lifesaving, although the safety of this policy must be assessed.
Methods: This is a nationwide, prospective study, reporting the experience on the utilization of non-lung organs from SARS-CoV-2-positive donors between December 15, 2020 and May 31, 2022 in Spain.
Results: A total of 69 patients received a solid organ transplant (41 kidney, 18 liver, 8 heart, and 2 combined liver-kidney) obtained from 32 donors with a positive SARS-CoV-2 PCR at the time of donation (four of them with a cycle threshold value <30). All recipients tested negative for SARS-CoV-2 and were free of coronavirus disease 2019 (COVID-19) symptoms prior to transplantation. Nasopharyngeal swab turned positive for SARS-CoV-2 PCR in 4 (5.8%) recipients at 3, 8, 11, and 20 days after transplantation, though evidence did not support a donor-derived COVID-19. Four kidney recipients lost their grafts and two patients died: one heart recipient due to cardiogenic shock and one combined liver-kidney recipient due to lung hypertension and right heart failure. Graft losses and patient deaths were deemed unrelated to the donor SARS-CoV-2 status by the treating teams. No other adverse reactions were reported.
Conclusions: This preliminary experience supports the safety of the use of organs other than lungs from SARS-CoV-2 PCR-positive donors, in alignment with previous series. However, the impact of SARS-CoV-2 infection upon organ quality should be established in future research.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/tid.14008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe.
Transpl Int
December 2024
Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-Azienda Socio Sanitaria Territoriale (ASST)-Sette Laghi, Varese, Italy.
SARS-CoV-2 infection represents a new challenge for solid organ transplantation (SOT) with evolving recommendations. A cross-sectional survey was performed (February-June 2024) to describe practices among Member States of the Council of Europe (COE) on the use of organs from deceased donors with resolved or active SARS-CoV-2 infection. Overall, 32 out of 47 Member States with a transplant program participated in the study.
View Article and Find Full Text PDFCorrelation between blood cell indices and adiponectin and leptin levels in COVID-19.
Biomol Biomed
October 2024
Department of Radiobiology and Molecular Genetics, “VINCA” Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
Article Synopsis
- Adipose tissue (AT) acts as a key metabolic organ and influences various bodily functions through hormonal mechanisms; this study focused on its role during COVID-19 by examining relationships between adipokines and blood cell indices in infected individuals.
- The research involved 76 COVID-19 patients and found that higher leptin levels correlated positively with body mass index (BMI) and body fat mass, while adiponectin showed an inverse relationship with BMI.
- The study also linked leptin levels to increased platelet metrics, suggesting that AT might contribute to the complex immune response during COVID-19, thus providing insights into its pathophysiology.
Mortality in hospitalized SARS-CoV-2 patients with contemporaneous bacterial and fungal infections.
Antimicrob Steward Healthc Epidemiol
September 2024
Information Services, ECU Health, Greenville, NC, USA.
Background: The interplay between SARS-CoV-2 and contemporaneous bacterial or fungal culture growth may have crucial implications for clinical outcomes of hospitalized patients. This study aimed to quantify the effect of microbiological culture positivity on mortality among hospitalized patients with SARS-CoV-2.
Methods: In this retrospective cohort study, we included adult hospitalized patients from OPTUM COVID-19 specific data set, who tested positive for SARS-CoV-2 within 14 days of hospitalization between 01/20/2020 and 01/20/2022.
Presentations and Outcomes Among Infants ≤90 Days With and Without SARS-CoV-2.
Pediatrics
April 2024
Section of Pediatric Emergency Medicine, Department of Pediatrics.
Objectives: To compare symptoms and outcomes among infants aged ≤90 days tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a broad, international sample of emergency departments (EDs).
Methods: This was a secondary analysis of infants aged 0 to 90 days with suspected SARS-CoV-2 infections tested using molecular approaches and with 14-day follow-up. The parent studies were conducted at 41 EDs in 10 countries (the global Pediatric Emergency Research Network; March 2020-June 2021) and 14 EDs across Canada (Pediatric Emergency Research Canada network; August 2020-February 2022).
Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased Utilization.
Transplant Direct
April 2024
Department of Surgery, Houston Methodist Hospital, Houston, TX.
Background: The COVID-19 pandemic has led to an increase in SARS-CoV-2-test positive potential organ donors. The benefits of life-saving liver transplantation (LT) must be balanced against the potential risk of donor-derived viral transmission. Although emerging evidence suggests that the use of COVID-19-positive donor organs may be safe, granular series thoroughly evaluating safety are still needed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!